Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
'I bought hepatitis C cure from Bangladesh'

Zoe Sharam bought a hepatitis C cure, deemed too expensive for her by the NHS, online from Bangladesh. She speaks to the BBC's Victoria Derbyshire programme.

Published
02 March 2017
From
BBC Health
Hepatitis C drugs re-energize global fight over patents

The liver disease hepatitis C is the new battleground for lawsuits intended to slash the cost of life-saving medicines. In February alone, five suits were filed in India and Argentina claiming that the latest class of antiviral drugs does not warrant the 20-year patent monopoly that manufacturers have sought in those countries.

Published
01 March 2017
From
Nature
The Hepatitis C Trust and NAT respond to spit hoods debate

The Hepatitis C Trust and NAT (National AIDS Trust) have expressed concern about recent press coverage around the use of ‘spit hoods’ by police forces in the UK that has focused on their supposed value in preventing hepatitis C and HIV transmission.

Published
28 February 2017
From
Hepatitis C Trust
Hepatitis A outbreaks among men who have sex with men: three clusters reported across 13 countries

Between February 2016 and February 2017, three clusters involving 287 confirmed cases of hepatitis A (HAV) have been reported across 13 EU countries: Austria, Belgium, Denmark, Finland, France, Germany, Italy, Ireland, the Netherlands, Portugal, Spain, Sweden and the United Kingdom. Most of the notified cases were among men who have sex with men (MSM) who had not been vaccinated against HAV.

Published
28 February 2017
From
ECDC
Ukraine signs amicable agreement with Gilead on hepatitis C drug

Ukraine has signed an amicable agreement with U.S. Gilead Sciences, Inc. biopharmaceutical company on the Sovaldi medicine used to treat chronic hepatitis C infection in adults, acting Ukrainian Health Minister Ulana Suprun said at a press conference on Wednesday. The whole course of hepatitis C treatment with the use of Sovaldi in Ukraine will cost about $750.

Published
27 February 2017
From
Interfax Ukraine
Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?

People with HIV and hepatitis C virus (HCV) co-infection who are successfully treated for hepatitis C using interferon-free direct-acting antiviral (DAA) therapy do not appear to have

Published
27 February 2017
By
Liz Highleyman
Egypt targets hepatitis C patients for medical tourism

In mid 2016, Prime Pharma, a private Egyptian pharmaceutical company, launched Tour n’ Cure to revive therapeutic tourism in Egypt. The first target is hepatitis C patients from around the world. Countries targeted are Spain, Belgium, Italy, Netherlands and the UK.

Published
24 February 2017
From
International Medical Tourism Journal
Messi visits Egypt to promote Hepatitis C treatment

Supported by the Egyptian ministries of tourism and aviation, Prime Pharma started a campaign titled “Tour n’ Cure” to promote tourism treatment in Egypt, with Messi being chosen as ambassador for the campaign worldwide.

Published
22 February 2017
From
Daily News Egypt
Deal reduces price of life-saving hepatitis C drugs for Canadians

Tens of thousands of Canadian patients with mild versions of chronic hepatitis C could soon receive public funding for medications that cure the infection now that the provinces have sealed a deal with three pharmaceutical companies to reduce the cost of the ultra-expensive drugs.

Published
22 February 2017
From
The Globe and Mail
HCV Infection Linked to Nonhepatic Cancers in the Elderly

Hepatitis C virus (HCV) infection may be linked to cancers other than hepatocellular carcinoma (HCC), such as bile duct cancers and diffuse large B-cell lymphoma (DLBCL), according to a study published in Cancer.

Published
21 February 2017
From
Infectious Disease Advisor

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.